Antiproliferative effect of dexamethasone in the MCF-7 breast cancer cell line

Glucocorticoids (GCs) are used in the treatment of cancer to induce programmed cell death in the transformed cells of the hematopoietic system and to reduce side effects. Additionally, GCs are described as an inhibitor of certain chemotherapy or radiation-induced apoptosis and also an inhibitor of cancer progression by downregulating or upregulating the expression of several genes. The present study used immunofluorescence to investigate the presence of the glucocorticoid receptor (GR) in MCF-7 cells, and the cell culture growth was determined by cell counting the number of cells following exposure to GC and/or dexamethasone (Dex). The presence and immunoreactivity of the GR were confirmed, and treatment with Dex (10−8–10−7 M) caused an inhibitory effect (30–35%) on the proliferative activity of the MCF-7 cells. This growth inhibitory effect was possibly produced by the pro-apopotic effect of Dex. Since Dex is administered systematically prior to breast cancer chemotherapy, the possible interactions between these drugs require further investigation.

[1]  P. Forgez,et al.  Loss of glucocorticoid receptor activation is a hallmark of BRCA1-mutated breast tissue , 2013, Breast Cancer Research and Treatment.

[2]  S. Conzen,et al.  Glucocorticoid Receptor Antagonism as a Novel Therapy for Triple-Negative Breast Cancer , 2013, Clinical Cancer Research.

[3]  T. Lash,et al.  Use of glucocorticoids and risk of breast cancer: a Danish population-based case-control study , 2012, Breast Cancer Research.

[4]  Robert H. Oakley,et al.  Cellular Processing of the Glucocorticoid Receptor Gene and Protein: New Mechanisms for Generating Tissue-specific Actions of Glucocorticoids* , 2010, The Journal of Biological Chemistry.

[5]  J. Noël,et al.  Estrogen Receptor, Progesterone Receptor, and Glucocorticoid Receptor Expression in Normal Breast Tissue, Breast In Situ Carcinoma, and Invasive Breast Cancer , 2010, Applied immunohistochemistry & molecular morphology : AIMM.

[6]  D. DeFranco,et al.  Glucocorticoids antagonize estrogens by glucocorticoid receptor-mediated activation of estrogen sulfotransferase. , 2008, Cancer research.

[7]  A. Papavassiliou,et al.  The glucocorticoid receptor signalling in breast cancer. , 2007, Journal of cellular and molecular medicine.

[8]  M. Arenas,et al.  Glucocorticoid receptor changes its cellular location with breast cancer development. , 2008, Histology and histopathology.

[9]  J. Ferlay,et al.  Burden of cervical cancer in the 27 member states of the European Union: estimates for 2004. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  H. Friess,et al.  Corticosteroids induce chemotherapy resistance in the majority of tumour cells from bone, brain, breast, cervix, melanoma and neuroblastoma. , 2006, International journal of oncology.

[11]  H. Lien,et al.  Differential expression of glucocorticoid receptor in human breast tissues and related neoplasms , 2006, The Journal of pathology.

[12]  Jeffrey N Miner,et al.  The search for safer glucocorticoid receptor ligands. , 2005, Endocrine reviews.

[13]  Wei Wu,et al.  Glucocorticoid Receptor-induced MAPK Phosphatase-1 (MPK-1) Expression Inhibits Paclitaxel-associated MAPK Activation and Contributes to Breast Cancer Cell Survival* , 2005, Journal of Biological Chemistry.

[14]  Wei Wu,et al.  Microarray Analysis Reveals Glucocorticoid-Regulated Survival Genes That Are Associated With Inhibition of Apoptosis in Breast Epithelial Cells , 2004, Cancer Research.

[15]  Hui Wang,et al.  Dexamethasone as a chemoprotectant in cancer chemotherapy: hematoprotective effects and altered pharmacokinetics and tissue distribution of carboplatin and gemcitabine , 2004, Cancer Chemotherapy and Pharmacology.

[16]  M. Piccart,et al.  Use and abuse of taxanes in the management of metastatic breast cancer. , 2003, European journal of cancer.

[17]  D. Feldman,et al.  Estradiol inhibits glucocorticoid receptor expression and induces glucocorticoid resistance in MCF-7 human breast cancer cells , 2001, The Journal of Steroid Biochemistry and Molecular Biology.

[18]  P. Furth,et al.  Induction of bcl-xL expression in mammary epithelial cells is glucocorticoid-dependent but not signal transducer and activator of transcription 5-dependent. , 2000, Cancer research.

[19]  R. Kofler,et al.  The molecular basis of glucocorticoid-induced apoptosis of lymphoblastic leukemia cells , 2000, Histochemistry and Cell Biology.

[20]  J. Cidlowski,et al.  Delineation of an Antiapoptotic Action of Glucocorticoids in Hepatoma Cells: The Role of Nuclear Factor-κB. , 2000, Endocrinology.

[21]  J. Cidlowski,et al.  Delineation of an antiapoptotic action of glucocorticoids in hepatoma cells: the role of nuclear factor-kappaB. , 2000, Endocrinology.

[22]  Miguel Beato,et al.  Steroid hormone receptors: Many Actors in search of a plot , 1995, Cell.

[23]  D. Kaufman,et al.  Multihormonal regulation of insulin-like growth factor-I-related protein in MCF-7 human breast cancer cells. , 1988, Molecular endocrinology.

[24]  P. Chambon,et al.  Cloning of the human glucocorticoid receptor cDNA. , 1985, Nucleic acids research.

[25]  M. Lippman,et al.  The effects of glucocorticoids and progesterone on hormone-responsive human breast cancer in long-term tissue culture. , 1976, Cancer research.